Mestastop Solutions
Bangalore, India· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Mestastop Solutions develops proprietary platforms to unravel metastasis biology for drug discovery and companion diagnostics in oncology.
Oncology
Technology Platform
Three proprietary platforms (METAssay®, METVivo®, METSCAN®) that integrate wet lab biology with machine learning to dissect metastasis into 30 functional steps for drug discovery and companion diagnostics.
Opportunities
Large unmet need in metastasis prevention across multiple solid tumors, potential for companion diagnostics to guide adjuvant therapy decisions, and opportunities for partnerships with pharmaceutical companies seeking metastasis-focused assets.
Risk Factors
Clinical validation of metastasis-focused therapeutics has historically been challenging, competition from larger oncology diagnostics companies, and dependence on successful translation of platform technology into approved products.
Competitive Landscape
Few companies specialize specifically in metastasis biology; Mestastop differentiates through its integrated platform approach combining functional assays, animal models, and patient-derived data with machine learning analytics.